Bachelor of Science

Newmont Appoints Mining Industry Veteran Francois Hardy as Chief Technology Officer

Retrieved on: 
Friday, April 19, 2024
Mining, Minerals, Natural Resources, NEM, University, Technikon, Technikon Witwatersrand, Corporation, TSX, ASX, University of Johannesburg, Bachelor of Science, Mining engineering, De Beers, Multimedia, NGT, Growth, Management

Newmont Corporation (NYSE: NEM, TSX: NGT, ASX: NEM, PNGX: NEM) today announced the appointment of Francois Hardy as Chief Technology Officer (CTO).

Key Points: 
  • Newmont Corporation (NYSE: NEM, TSX: NGT, ASX: NEM, PNGX: NEM) today announced the appointment of Francois Hardy as Chief Technology Officer (CTO).
  • View the full release here: https://www.businesswire.com/news/home/20240419973025/en/
    Newmont Appoints Mining Industry Veteran Francois Hardy as Chief Technology Officer (Photo: Business Wire)
    Francois will take over from interim CTO, Dean Gehring , who also served in a dual role as Newmont’s Chief Integration Officer.
  • Francois brings more than 30 years of technical and operational experience in mining to the role.
  • Francois will be based at Newmont’s headquarters in Denver and will assume his new role as of May 1, 2024.

Curida, Small Molecules and Biologics CDMO, Secures Private Equity Investment from Signet Healthcare Partners

Retrieved on: 
Tuesday, April 16, 2024
Research, Finance, Clinical Trials, Professional Services, Biotechnology, Health, Pharmaceutical, Other Science, Science, Asepsis, Partnership, University of Gothenburg, Chalmers University of Technology, Chemical engineering, Orkla, CDMO, Imperial College London, Therapy, Bachelor of Science, Patient, Master of Science, BFS, Philosophy, Drug development, GMP, Thermo Fisher Scientific, Growth, Carlsberg, Management

Curida Holding AS (“Curida”) has announced a significant growth investment from Signet Healthcare Partners (“Signet”), a New York-based healthcare private equity firm.

Key Points: 
  • Curida Holding AS (“Curida”) has announced a significant growth investment from Signet Healthcare Partners (“Signet”), a New York-based healthcare private equity firm.
  • This strategic partnership will enable Curida to accelerate its expansion plans, including enhancing facility capabilities and growing its industry position.
  • Curida’s customer base ranges from small to medium-sized pharmaceutical, medical devices, and biotech companies, delivering solutions in drug development and GMP manufacturing globally.
  • In conjunction with Signet’s investment, Signet is joining the Board of Directors, and Ole J. Dahlberg has been appointed as Chairman of the Board.

Former Architect of the U.S. Capitol Alan Hantman presents CCNY's Rudin Lecture, May 2

Retrieved on: 
Wednesday, April 24, 2024
FAIA, Advisory Council, Congress, CCNY, Lecture, Library, Architect, CUNY, Supreme court, CBS News, Dean, Nobel Prize, Dome, NBC News, History, Bachelor of Architecture, Senate, Growth, Engineering, Bachelor of Science, American Institute, Bachelor, Hantman, Communication, Graduate Center, CUNY, Multimedia, National Garden, Athens, RSVP, Capitol Power Plant, Politics, Great hall

NEW YORK, April 24, 2024 /PRNewswire/ -- Alan M. Hantman , the 10th Architect of the U.S. Capitol, returns to his alma mater on May 2 as the 2024 Samuel Rudin Distinguished Visiting Scholar .

Key Points: 
  • NEW YORK, April 24, 2024 /PRNewswire/ -- Alan M. Hantman , the 10th Architect of the U.S. Capitol, returns to his alma mater on May 2 as the 2024 Samuel Rudin Distinguished Visiting Scholar .
  • Copies of the book will be available for purchase at the lecture, and Hantman will sign copies after the lecture.
  • Hantman was in the first graduating class of what became CCNY's Bernard and Anne Spitzer School of Architecture .
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/former-architect-of-the-us-capi...
    SOURCE City College of New York, Office of Institutional Advancement and Communications

Visionary Holdings Inc. Announcement of Management Change

Retrieved on: 
Wednesday, April 24, 2024
GV, EMBA, Physics, Artificial intelligence, Nanyang Technological University, Bachelor of Science, MBA, The Company

Mr. Chen has over 27 years of experience in development, construction, and architectural management.

Key Points: 
  • Mr. Chen has over 27 years of experience in development, construction, and architectural management.
  • He has been serving as the President of Addington Development in Toronto, Canada since 2010.
  • Under his leadership, the company has successfully raised over $150 million CAD through various financings and improved construction processes, reducing costs by 15%.
  • Mr. Chen holds an Executive MBA (EMBA) from Nanyang Technological Institute in Singapore.

BayCare Names Jimmy Baumgartner as Vice President of BayCare HomeCare and Post-Acute Care

Retrieved on: 
Wednesday, April 17, 2024
University, Jimmy, Hospital, Business administration, Research, Florida State University, Children's Hospital, Joint Commission, Bachelor of Science, Patient, Child, Nursing

CLEARWATER, Fla., April 17, 2024 /PRNewswire/ -- BayCare announced today that Jimmy Baumgartner has been named vice president of BayCare HomeCare and post-acute care, effective immediately.

Key Points: 
  • CLEARWATER, Fla., April 17, 2024 /PRNewswire/ -- BayCare announced today that Jimmy Baumgartner has been named vice president of BayCare HomeCare and post-acute care, effective immediately.
  • He has been serving as the interim vice president of BayCare HomeCare since January 2024.
  • Baumgartner first joined BayCare HomeCare as director of operations in January 2023.
  • "This is an amazing opportunity to lead the best team in home care, and I am so grateful," said Baumgartner.

Slone Partners Places Chris Raanes as CEO at Magnetic Insight

Retrieved on: 
Tuesday, April 16, 2024
Radiation, MPI, Research, Growth, Bachelor of Science, SVP, Senior, Patient, Organization, Health, Management

SOUTH RIDING, Va., April 16, 2024 /PRNewswire-PRWeb/ -- Slone Partners, a nationwide executive search firm for life sciences, healthcare, and nonprofit and social impact organizations, has announced the placement of Chris A. Raanes as Chief Executive Officer (CEO) at Magnetic Insight, the global leader in magnetic particle imaging (MPI).

Key Points: 
  • SOUTH RIDING, Va., April 16, 2024 /PRNewswire-PRWeb/ -- Slone Partners , a nationwide executive search firm for life sciences, healthcare, and nonprofit and social impact organizations, has announced the placement of Chris A. Raanes as Chief Executive Officer (CEO) at Magnetic Insight , the global leader in magnetic particle imaging (MPI).
  • Raanes has more than 20 years of experience in the medical device sector, having led companies through pivotal stages of growth and commercialization.
  • "I'm honored to join the Magnetic Insight team, especially at such a pivotal time for groundbreaking research and advancements in the MPI space," said Raanes.
  • Raanes earned his Bachelor of Science and his Master of Science degrees in Electrical Engineering from the Massachusetts Institute of Technology.

Caledonia Mining Corporation Plc: Appointment of Chief Operating Officer

Retrieved on: 
Monday, April 8, 2024
The Company, Ageing, Gold, Bachelor of Science, Copper, MBA, Nickel, Harmony Gold (mining), Region, Harmony Gold, Bilboes, Mining engineering, Blanket, Mining

ST HELIER, Jersey, April 08, 2024 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc ("Caledonia" or the "Company") (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) is pleased to announce that James Mufara (aged 49) has agreed to join the Caledonia group as Chief Operating Officer with effect from May 1, 2024.

Key Points: 
  • ST HELIER, Jersey, April 08, 2024 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc ("Caledonia" or the "Company") (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) is pleased to announce that James Mufara (aged 49) has agreed to join the Caledonia group as Chief Operating Officer with effect from May 1, 2024.
  • James was previously at Harmony Gold Mining Company Limited where, as Regional General Manager, he headed a complex portfolio of operations consisting of five mines and 15,000 staff, mining 450koz of gold per annum.
  • James has over 25 years’ experience in the mining sector in Southern Africa, including 13 years in leadership roles.
  • His career has been primarily gold focused, but also with exposure to nickel, copper, and chrome mining.

Koryx Copper Intersects 168.60 Metres at 0.40% Cu Eq Including Multiple 2 m Intersections >1.00% Cu Eq and 34.00 m at 0.73% Cu Eq Including 2 m at 2.28% Cu Eq

Retrieved on: 
Thursday, April 4, 2024
Element, Quality control, Molybdenum, National Instrument 43-101, Mineral Resources Limited, ALS, ICP, Copper, Bachelor of Science, Gold, News, Laboratory, Geology, National instrument, Qualified person (European Union), Honours degree, Planview, Road

VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Koryx Copper Inc. ("Koryx" or “the Company") (TSX-V: KRY) announces the third assay results from its current drilling program at its Haib Copper project in southern Namibia.  The Company’s latest four drill holes continue to confirm that the deposit can deliver high grades over substantial widths within the known historical resource.

Key Points: 
  • CuEq (copper equivalent) has been used to express the combined value of copper and molybdenum and is provided for illustrative purposes only.
  • Also half-way up the southern slope it too was positioned to close the sample spacing in this part of Pit1.
  • HM39 was drilled west of and parallel to HM34 and was positioned to close the sample spacing in this direction.
  • Over time, it has seen several transformations including shearing and faulting events that appear to have further concentrated Cu and Mo.

Former CEOs of JetBlue, Maersk Drilling, and Public Service Enterprise Group (PSEG) join Avina Clean Hydrogen’s distinguished advisory board

Retrieved on: 
Wednesday, April 3, 2024
Hydrogen, Physics, Maersk Drilling, University, AP, BP, Advisory board, U.S. Steel, Electronic, Steel, Independent, Copenhagen Business School, Bachelor of Science, Aviation, Columbia University, Public Service Enterprise Group, Risk intelligence, Robin, MBA, Doctor of Philosophy, JetBlue, CSR, Former, Electrical engineering, Maersk, Engineering, Management

SHORT HILLS, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Avina Clean Hydrogen is excited to announce the appointment of three renowned industry leaders to its Advisory Board.

Key Points: 
  • SHORT HILLS, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Avina Clean Hydrogen is excited to announce the appointment of three renowned industry leaders to its Advisory Board.
  • Ltd., and Ralph Izzo, Former Chairman and CEO of Public Service Enterprise Group (PSEG), join the existing distinguished panel of advisory board members, bringing valuable expertise and insight to the company's projects in the clean fuels sector.
  • "We are thrilled to welcome our new Advisory Board members," said Vishal Shah, Founder & CEO of Avina Clean Hydrogen.
  • Their expertise will complement our existing prestigious Advisory Board members, enabling us to collaborate effectively in building a world-class company that delivers compelling clean fuel solutions to the market,” said Steven Berkenfeld, Board Member of Avina.

ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer

Retrieved on: 
Tuesday, April 2, 2024
Clinical research, Molecular medicine, AstraZeneca, Entrepreneurship, Patient, SAN, Mayo Clinic, Research, RNA, Bachelor of Science, Lead, University, MD, Senior, Sympathetic nervous system, Biology, Therapy, Destiny, Division, CMO, Amgen, DSM-IV codes, Pharmaceutical industry

SAN DIEGO, April 02, 2024 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a clinical stage biotechnology company developing next generation RNA therapeutics, today announced the appointment of Chris Storgard, M.D., as Chief Medical Officer (CMO).

Key Points: 
  • SAN DIEGO, April 02, 2024 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a clinical stage biotechnology company developing next generation RNA therapeutics, today announced the appointment of Chris Storgard, M.D., as Chief Medical Officer (CMO).
  • As CMO, Dr. Storgard will lead Clinical Research, Clinical Operations, Biometrics, Pharmacovigilance and Medical Affairs.
  • Dr. Storgard has a BSc in biology and an MD from the University of Saskatchewan in Canada.
  • Dr. Storgard completed a fellowship in rheumatology at Scripps Clinic and Research Center in San Diego, CA.